{"id":3231,"date":"2013-04-12T09:45:00","date_gmt":"2013-04-12T09:45:00","guid":{"rendered":"https:\/\/www.xvivogroup.com\/us\/mfn_news\/clarification-of-xvivo-perfusions-rights-to-professor-stig-steens-media-for-the-preservation-and-evaluation-of-organs\/"},"modified":"2013-04-12T09:45:00","modified_gmt":"2013-04-12T09:45:00","slug":"clarification-of-xvivo-perfusions-rights-to-professor-stig-steens-media-for-the-preservation-and-evaluation-of-organs","status":"publish","type":"mfn_news","link":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/clarification-of-xvivo-perfusions-rights-to-professor-stig-steens-media-for-the-preservation-and-evaluation-of-organs\/","title":{"rendered":"Clarification of XVIVO Perfusion\u2019s rights to Professor Stig Steen\u2019s media for the preservation and evaluation of organs"},"content":{"rendered":"<\/p>\n

Due to the insufficient information that Vivoline Medical has distributed in a Memorandum (including supplementary information that was recently published) ahead of its planned new share issue and listing on AktieTorget, XVIVO Perfusion feels obliged to provide information on the exclusive global unlimited rights that XVIVO Perfusion has to certain media developed by Professor Stig Steen and Vivoline Medical for the evaluation and preservation of organs in connection with transplantation.<\/span><\/p>\n<\/p>\n

Pursuant to the current agreement with Professor Stig Steen and Igel\u00f6sa Life Science AB, XVIVO Perfusion has global unlimited irrevocable exclusive rights to media and related patents for the preservation and evaluation of organs, media which are based on LPD (low potassium dextran) such as Perfadex\u00ae<\/sup>, with added calcium, created by Professor Stig Steen and Vivoline Medical. <\/span><\/p>\n<\/p>\n

Several of Vivoline Medical\u2019s patent rights mentioned in its Memorandum are for media created by Professor Stig Steen for the preservation and evaluation of organs, media which are based on LPD with added calcium. These patents are thus covered by XVIVO Perfusion\u2019s exclusive rights.<\/p>\n

XVIVO Perfusion\u2019s product STEEN Solution<\/span>\u2122<\/span> is protected by a patent which is valid until the year 2021 and which covers evaluation and preservation solutions containing LPD in combination with the high concentrations of albumin that are considered necessary to create an effective protective environment for the organs being evaluated and stored.<\/span><\/p>\n<\/p>\n

Magnus Nilsson, CEO of XVIVO Perfusion: \u201cXVIVO Perfusion intends to continue developing and commercializing Professor Stig Steen\u2019s media in the best way possible so as to create value for patients, customers and shareholders.\u201d<\/span><\/p>\n<\/p>\n

April 12, 2013
<\/span>Gothenburg<\/span>
<\/span>XVIVO Perfusion AB (publ)<\/span><\/p>\n<\/p>\n

\n

For further information please contact:
<\/span>Christoffer Rosenblad, CFO, +46 31\u00a0788 21 59,\u00a0christoffer.rosenblad@xvivoperfusion.com<\/a><\/span>
<\/span><\/p>\n

Xvivo Perfusion is required to publish the information in this press release in accordance with the Swedish Securities Market Act and\/or the Financial Instruments Trading Act. The information was submitted for publication on\u00a0April 12, 2013\u00a0at 11:45 a.m.<\/span><\/p>\n

This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.<\/span><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Due to the insufficient information that Vivoline Medical has distributed in a Memorandum (including supplementary information that was recently published)…<\/p>\n","protected":false},"template":"","class_list":["post-3231","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-lang-en","mfn-news-tag-mfn-regulatory","mfn-news-tag-mfn-regulatory-vpml","mfn-news-tag-mfn-ci","mfn-news-tag-mfn-ci-other"],"acf":[],"yoast_head":"\nClarification of XVIVO Perfusion\u2019s rights to Professor Stig Steen\u2019s media for the preservation and evaluation of organs - XVIVO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/clarification-of-xvivo-perfusions-rights-to-professor-stig-steens-media-for-the-preservation-and-evaluation-of-organs\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Clarification of XVIVO Perfusion\u2019s rights to Professor Stig Steen\u2019s media for the preservation and evaluation of organs - XVIVO\" \/>\n<meta property=\"og:description\" content=\"Due to the insufficient information that Vivoline Medical has distributed in a Memorandum (including supplementary information that was recently published)...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/clarification-of-xvivo-perfusions-rights-to-professor-stig-steens-media-for-the-preservation-and-evaluation-of-organs\/\" \/>\n<meta property=\"og:site_name\" content=\"United States\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/clarification-of-xvivo-perfusions-rights-to-professor-stig-steens-media-for-the-preservation-and-evaluation-of-organs\\\/\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/clarification-of-xvivo-perfusions-rights-to-professor-stig-steens-media-for-the-preservation-and-evaluation-of-organs\\\/\",\"name\":\"Clarification of XVIVO Perfusion\u2019s rights to Professor Stig Steen\u2019s media for the preservation and evaluation of organs - XVIVO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\"},\"datePublished\":\"2013-04-12T09:45:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/clarification-of-xvivo-perfusions-rights-to-professor-stig-steens-media-for-the-preservation-and-evaluation-of-organs\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/clarification-of-xvivo-perfusions-rights-to-professor-stig-steens-media-for-the-preservation-and-evaluation-of-organs\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/clarification-of-xvivo-perfusions-rights-to-professor-stig-steens-media-for-the-preservation-and-evaluation-of-organs\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Clarification of XVIVO Perfusion\u2019s rights to Professor Stig Steen\u2019s media for the preservation and evaluation of organs\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\",\"name\":\"United States\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Clarification of XVIVO Perfusion\u2019s rights to Professor Stig Steen\u2019s media for the preservation and evaluation of organs - XVIVO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/clarification-of-xvivo-perfusions-rights-to-professor-stig-steens-media-for-the-preservation-and-evaluation-of-organs\/","og_locale":"en_US","og_type":"article","og_title":"Clarification of XVIVO Perfusion\u2019s rights to Professor Stig Steen\u2019s media for the preservation and evaluation of organs - XVIVO","og_description":"Due to the insufficient information that Vivoline Medical has distributed in a Memorandum (including supplementary information that was recently published)...","og_url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/clarification-of-xvivo-perfusions-rights-to-professor-stig-steens-media-for-the-preservation-and-evaluation-of-organs\/","og_site_name":"United States","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/clarification-of-xvivo-perfusions-rights-to-professor-stig-steens-media-for-the-preservation-and-evaluation-of-organs\/","url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/clarification-of-xvivo-perfusions-rights-to-professor-stig-steens-media-for-the-preservation-and-evaluation-of-organs\/","name":"Clarification of XVIVO Perfusion\u2019s rights to Professor Stig Steen\u2019s media for the preservation and evaluation of organs - XVIVO","isPartOf":{"@id":"https:\/\/www.xvivogroup.com\/us\/#website"},"datePublished":"2013-04-12T09:45:00+00:00","breadcrumb":{"@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/clarification-of-xvivo-perfusions-rights-to-professor-stig-steens-media-for-the-preservation-and-evaluation-of-organs\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.xvivogroup.com\/us\/pressreleases\/clarification-of-xvivo-perfusions-rights-to-professor-stig-steens-media-for-the-preservation-and-evaluation-of-organs\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/clarification-of-xvivo-perfusions-rights-to-professor-stig-steens-media-for-the-preservation-and-evaluation-of-organs\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.xvivogroup.com\/us\/"},{"@type":"ListItem","position":2,"name":"Clarification of XVIVO Perfusion\u2019s rights to Professor Stig Steen\u2019s media for the preservation and evaluation of organs"}]},{"@type":"WebSite","@id":"https:\/\/www.xvivogroup.com\/us\/#website","url":"https:\/\/www.xvivogroup.com\/us\/","name":"United States","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.xvivogroup.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news\/3231","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/media?parent=3231"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}